SCHEMBL8621773

SCHEMBL8621773

CC1(C)C=C(c2ccc(F)cc2)C(c2ccccc2S(N)(=O)=O)=C1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.48
PTGS1 P23219 6/20 0.48
ALOX5AP P20292 5/20 0.40
FEN1 P39748 5/20 0.40
TRPV1 Q8NER1 1/20 0.40
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA9 Q16790 2/20 0.37
ENPP3 O14638 1/20 0.37
HSD11B1 P28845 1/20 0.36
CA12 O43570 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL215543 0.87 PTGS2 (0.49) PTGS2PTGS1ALOX5APFEN1HSD11B1
Sulfamide SCHEMBL4639024 0.82 PTGS2 (0.45) PTGS2PTGS1CA1CA2CA9
SCHEMBL214628 0.79 PTGS2 (0.56) PTGS2PTGS1CA1CA2CA9
SCHEMBL2568289 0.78 PTGS2 (0.68) PTGS2PTGS1ALOX5APFEN1TRPV1
Hydrochloric Acid SCHEMBL5794623 0.77 PTGS2 (0.66) PTGS2PTGS1ALOX5APFEN1TRPV1
SCHEMBL8657273 0.76 PTGS2 (0.69) PTGS2PTGS1ALOX5APFEN1TRPV1
SCHEMBL5668728 0.75 PTGS1 (0.41) PTGS2PTGS1ALDH1A1GAA
SCHEMBL8658158 0.74 PTGS2 (0.53) PTGS2PTGS1ALOX5APFEN1TRPV1
SCHEMBL8974740 0.72 CA1 (0.41) PTGS2PTGS1CA1CA2CA4
SCHEMBL851339 0.71 PTGS2 (0.71) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998016227-A9 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA 1998-07-30 WO claimed